3.8 Article

Newborn Screening for SCID: Experience in Spain (Catalonia)

Journal

Publisher

MDPI
DOI: 10.3390/ijns7030046

Keywords

newborn screening; severe combined immunodeficiency; T-cell receptor excision circles; T-lymphocytes; stem cell transplantation; PNP deficiency; TREC; SCID; NBS Spain; NBS Catalonia

Ask authors/readers for more resources

Newborn screening for severe combined immunodeficiency (SCID) was initiated in Catalonia in 2017, making it the first region in Spain and Europe to include this testing universally. The results from Catalonia show that early diagnosis and treatment through newborn screening programs can benefit patients with SCID and non-SCID, highlighting the importance of a national screening program in Spain to better understand the exact incidence of SCID.
Newborn screening (NBS) for severe combined immunodeficiency (SCID) started in Catalonia in January-2017, being the first Spanish and European region to universally include this testing. In Spain, a pilot study with 5000 samples was carried out in Seville in 2014; also, a research project with about 35,000 newborns will be carried out in 2021-2022 in the NBS laboratory of Eastern Andalusia. At present, the inclusion of SCID is being evaluated in Spain. The results obtained in the first three and a half years of experience in Catalonia are presented here. All babies born between January-2017 and June-2020 were screened through TREC-quantification in DBS with the Enlite Neonatal TREC-kit from PerkinElmer. A total of 222,857 newborns were screened, of which 48 tested positive. During the study period, three patients were diagnosed with SCID: an incidence of 1 in 74,187 newborns; 17 patients had clinically significant T-cell lymphopenia (non-SCID) with an incidence of 1 in 13,109 newborns who also benefited from the NBS program. The results obtained provide further evidence of the benefits of early diagnosis and curative treatment to justify the inclusion of this disease in NBS programs. A national NBS program is needed, also to define the exact SCID incidence in Spain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available